Extended use of real-time continuous glucose monitoring in adults with insulin-requiring type 2 diabetes: Results from the first 26 weeks of the 2GO-CGM trial
EndocrinologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Diabetic medicine : a journal of the British Diabetic Association
- Publicado em
- 18 mar 2025
- Citações
- 4
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Extended use of real-time continuous glucose monitoring in adults with insulin-requiring type 2 diabetes: Results from the first 26 weeks of the 2GO-CGM trial
Claire S Lever, Jonathan A Williman, Alisa Boucsein, Antony Watson, Rachael S Sampson, Oscar T Sergel-Stringer, Celeste Keesing, Benjamin J Wheeler, Martin I de Bock, Ryan G Paul
Descritores MeSH
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents
- Blood Glucose Self-Monitoring
- Insulin
- Blood Glucose
- Glycated Hemoglobin
- Humans
- Hypoglycemia
- Male
- Middle Aged
Veja também
Estudos relacionados
- Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin-treated diabetes: A randomised, open-label, crossover trial
- Rapid improvements in glycemic management with use of continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin: 3-month analysis of the MOBILE study
- Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: the DELI transition trial
- Comparing Equil patch versus traditional catheter insulin pump in type 2 diabetes using continuous glucose monitoring metrics and profiles